Color Genomics Announces $45M in Series B Funding

Color Genomics announced a $45M investment led by General Catalyst with participation from Bono, singer-songwriter and philanthropist, and existing investors including Susan L. Wagner, 8VC, Khosla Ventures and Emerson Collective.
As quoted in the press release:

“We’re in the middle of one of the greatest shifts seen in health. Increased access to genetic information is enabling doctors and their
patients to create personalized plans for better prevention, detection and treatment of hereditary disease,” said Elad Gil, CEO and co-founder
of Color Genomics. “The new funding will go toward bringing even more people access to potentially life-saving genetic information and
building the open databases necessary to further global research and development around major diseases.”
Today’s investment brings Color’s total funding to $60M and the new additions to its board of directors bring strong expertise in finance,
health and business technology to the team. Susan Wagner co-founded BlackRock in 1988 and helped it become one of the world’s most
successful asset-management companies, holding a range of leadership positions including vice chairman until mid-2012. She continues to serve
on the boards of Apple, BlackRock, Swiss Re, Wellesley College and Hackley School. Hemant Taneja is a managing director at General Catalyst
with a portfolio that includes companies in health, education, and financial technologies.